MEA Website Survey: Why we’re asking about co-morbidities and ME/CFS | 03 April 2019

 

Dr Charles Shepherd, Hon. Medical Adviser, ME Association.

As part of our on-going collection of patient evidence that will be submitted to the NICE guideline committee later in the year, we are asking about the presence of what are called co-morbidities in this month’s website survey.

March survey results – Cognitive Dysfunction.

A co-morbid condition is a condition that is present in addition to having a primary diagnosis of ME/CFS.

In this case we are particularly interested in gathering evidence on the incidence of a number of conditions that are, or appear to be, more common in people with ME/CFS – when compared to a similar group of people who do not have ME/CFS.

The conditions we are specifically interested in are:

  • Endometriosis
  • Fibromyalgia
  • Hypermobility/Ehlers Danlos syndrome
  • Interstitial cystitis
  • Irritable Bowel Syndrome
  • Jaw Pain – Temperomandibular Jaw Dysfunction
  • Mastocytosis/Mast Cell Disease
  • Migraine type headaches
  • Multiple Chemical Sensitivities
  • Postural Orthostatic Tachycardia Syndrome (PoTS)

In some cases, there is both anecdotal and research information to support a link to ME/CFS – examples being hypermobility and PoTS.

In other cases, research evidence is limited, and the link is largely based on anecdotal reports.


You can find the website survey on the Homepage (about half-way down the page)


We are submitting this evidence to NICE because we believe it’s important for information on the presence of co-morbidities and management to appear in the new guideline on ME/CFS (expected in 2020).

Proper management of co-morbid conditions should form part of any ME/CFS management programme, especially where symptoms overlap with those of the primary diagnosis.

Evidence about co-morbidities can also be helpful when it comes to research into the causation of a condition such as ME/CFS – as there may be similar pathological mechanisms involved.

All of these conditions are covered in the 2019 ME Association clinical and research guide (‘The Purple Book’), which also has a section that summarises and references research into co-morbidity in ME/CFS.

Feedback

We would like to hear your experiences of co-morbidities and ME/CFS. Please leave comments below on the ME Association website, or join the discussion on our Facebook, Twitter and Instagram pages.

Alternatively, you can forward any comments via head office email.

Thank you.


The ME Association

Please help us to continue with our vital work

We are a national charity working hard to make the UK a better place for people whose lives have been devastated by an often-misunderstood neurological disease.

If you would like to support our efforts and ensure we are able to inform, support, advocate and invest in biomedical research, then please donate today.

Just click the image opposite to visit our JustGiving page for one-off donations or to establish a regular payment.

Or why not join the ME Association as a member and be part of our growing community? For a monthly (or annual) subscription you will also receive our exclusive ME Essential magazine.


ME Association Registered Charity Number 801279


 

ME CONNECT HELPLINE

0344 576 5326

Available every day of the week between these times: 10am - 12noon, 2pm - 4pm and 7pm - 9pm.

Calls cost the same as other standard landline numbers (starting 01 or 02). If you have a call package for your landline or mobile phone then calls will normally come out of your inclusive minutes.